Methods of using MEK inhibitors

Details Methods of using MEK inhibitors Methods of using MEK inhibitors

2011-08-16

2011-08-16

Anderson, James (Department: 1629)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

N-c doai

Reexamination Certificate

active

07999006

ABSTRACT:
The present invention provides methods of treating cancer by administering a compound of Formula I, or a pharmaceutically acceptable salt or solvate thereof, in combination with other cancer treatments.

REFERENCES:
patent: 4510139 (1985-04-01), Bailey
patent: 6048885 (2000-04-01), Takase et al.
patent: 6960614 (2005-11-01), Barrett et al.
patent: 6974878 (2005-12-01), Guram et al.
patent: 7141312 (2006-11-01), Richter et al.
patent: 7514564 (2009-04-01), Chen et al.
patent: 7598383 (2009-10-01), Marlow et al.
patent: 2004/0116710 (2004-06-01), Wallace et al.
patent: 2004/0192653 (2004-09-01), Munson et al.
patent: 2005/0049276 (2005-03-01), Kaufman et al.
patent: 2005/0049419 (2005-03-01), Wallace et al.
patent: 2005/0054701 (2005-03-01), Wallace et al.
patent: 2005/0153962 (2005-07-01), Nettekoven et al.
patent: 2005/0256123 (2005-11-01), Marlow et al.
patent: 2006/0030610 (2006-02-01), Koch et al.
patent: 2007/0105859 (2007-05-01), Isshiki et al.
patent: 2009/0156576 (2009-06-01), Aay et al.
patent: 1 262 176 (2002-12-01), None
patent: 1 780 197 (2007-05-01), None
patent: 2003-192592 (2003-07-01), None
patent: 2005-162727 (2005-06-01), None
patent: WO 89/03818 (1989-05-01), None
patent: WO 97/12613 (1997-04-01), None
patent: WO 98/37881 (1998-09-01), None
patent: WO 99/01421 (1999-01-01), None
patent: WO 99/01421 (1999-01-01), None
patent: WO 99/01426 (1999-01-01), None
patent: WO 00/35435 (2000-06-01), None
patent: WO 00/35436 (2000-06-01), None
patent: WO 00/37141 (2000-06-01), None
patent: WO 00/40235 (2000-07-01), None
patent: WO 00/40237 (2000-07-01), None
patent: WO 00/41505 (2000-07-01), None
patent: WO 00/41505 (2000-07-01), None
patent: WO 00/41994 (2000-07-01), None
patent: WO 00/42003 (2000-07-01), None
patent: WO 00/42022 (2000-07-01), None
patent: WO 00/42022 (2000-07-01), None
patent: WO 00/42029 (2000-07-01), None
patent: WO 01/05390 (2001-01-01), None
patent: WO 01/05391 (2001-01-01), None
patent: WO 01/05392 (2001-01-01), None
patent: WO 01/05393 (2001-01-01), None
patent: WO 01/19788 (2001-03-01), None
patent: WO 01/68619 (2001-09-01), None
patent: WO 01/77101 (2001-10-01), None
patent: WO 02/06213 (2002-01-01), None
patent: WO 03/037329 (2003-05-01), None
patent: WO 03/062189 (2003-07-01), None
patent: WO 03/062191 (2003-07-01), None
patent: WO 03/077855 (2003-09-01), None
patent: WO 03/077914 (2003-09-01), None
patent: WO 03/103590 (2003-12-01), None
patent: WO 2004/056789 (2004-07-01), None
patent: WO 2004/083167 (2004-09-01), None
patent: WO 2004/089876 (2004-10-01), None
patent: WO 2004/089876 (2004-10-01), None
patent: WO 2004/011347 (2004-12-01), None
patent: WO 2004/113347 (2004-12-01), None
patent: WO 2005/000818 (2005-01-01), None
patent: WO 2005/007616 (2005-01-01), None
patent: WO 2005/009975 (2005-02-01), None
patent: WO 2005/023251 (2005-03-01), None
patent: WO 2005/023759 (2005-03-01), None
patent: WO 2005/023759 (2005-03-01), None
patent: WO 2005/051300 (2005-06-01), None
patent: WO 2005/051301 (2005-06-01), None
patent: WO 2005/051301 (2005-06-01), None
patent: WO 2005/051302 (2005-06-01), None
patent: WO 2006/010594 (2006-02-01), None
patent: WO 2006/045514 (2006-05-01), None
patent: WO 2006/045514 (2006-05-01), None
patent: WO 2007/044515 (2007-04-01), None
patent: WO 2008/021389 (2008-02-01), None
Vippagunta. Adv. Drug Del. Rev., vol. 48, (2001), pp. 3-26.
Sausville et al. Cancer Research, 2006, vol. 66, pp. 3351-3354.
Johnson et al. British J. of Cancer, 2001, 84(10):1424-1431.
Shpiro, N. et al., “Improved Experimental Procedure for the Synthesis of the Potent MEK Inhibitor PD184352”, Synthetic Communications, vol. 35, 2005, 2265-2269.

Affiliated with

Also associated with

Rating

Methods of using MEK inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of using MEK inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of using MEK inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2661726